{
  "fullName": "Frederik Barkhof",
  "slug": "frederik-barkhof",
  "title": "MD",
  "specialty": "Neuroradiology",
  "geography": {
    "country": "United Kingdom",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 28,
  "hIndex": 178,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Frederik Barkhof is a neuroradiologist. He led the development of the Barkhof Criteria for using MRI findings to predict conversion to clinically definite multiple sclerosis.",
  "aiSummary": "Frederik Barkhof is a neuroradiology specialist with an H-index of 178 at University College London (Faculty). Has been published in The Lancet Neurology, Proceedings of the National Academy of Sciences, New England Journal of Medicine. Based in United Kingdom.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "University College London",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Neuroradiology"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria",
      "journal": "The Lancet Neurology",
      "year": 2017,
      "citationCount": 7552,
      "doi": "10.1016/s1474-4422(17)30470-2",
      "sourceUrl": "https://doi.org/10.1016/s1474-4422(17)30470-2",
      "verified": true
    },
    {
      "title": "Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration",
      "journal": "The Lancet Neurology",
      "year": 2013,
      "citationCount": 5203,
      "doi": "10.1016/s1474-4422(13)70124-8",
      "sourceUrl": "https://doi.org/10.1016/s1474-4422(13)70124-8",
      "verified": true
    },
    {
      "title": "Consistent resting-state networks across healthy subjects",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 2006,
      "citationCount": 4350,
      "doi": "10.1073/pnas.0601417103",
      "sourceUrl": "https://doi.org/10.1073/pnas.0601417103",
      "verified": true
    },
    {
      "title": "Defining the clinical course of multiple sclerosis",
      "journal": "Neurology",
      "year": 2014,
      "citationCount": 3003,
      "doi": "10.1212/wnl.0000000000000560",
      "sourceUrl": "https://doi.org/10.1212/wnl.0000000000000560",
      "verified": true
    },
    {
      "title": "Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis",
      "journal": "New England Journal of Medicine",
      "year": 2010,
      "citationCount": 2173,
      "doi": "10.1056/nejmoa0907839",
      "sourceUrl": "https://doi.org/10.1056/nejmoa0907839",
      "verified": true
    },
    {
      "title": "A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT",
      "journal": "Stroke",
      "year": 2001,
      "citationCount": 1766,
      "doi": "10.1161/01.str.32.6.1318",
      "sourceUrl": "https://doi.org/10.1161/01.str.32.6.1318",
      "verified": true
    },
    {
      "title": "Atrophy of medial temporal lobes on MRI in \"probable\" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.",
      "journal": "Journal of Neurology Neurosurgery & Psychiatry",
      "year": 1992,
      "citationCount": 1735,
      "doi": "10.1136/jnnp.55.10.967",
      "sourceUrl": "https://doi.org/10.1136/jnnp.55.10.967",
      "verified": true
    },
    {
      "title": "Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis",
      "journal": "Brain",
      "year": 1997,
      "citationCount": 1244,
      "doi": "10.1093/brain/120.11.2059",
      "sourceUrl": "https://doi.org/10.1093/brain/120.11.2059",
      "verified": true
    },
    {
      "title": "Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease",
      "journal": "The Journal of Prevention of Alzheimer s Disease",
      "year": 2022,
      "citationCount": 1219,
      "doi": "10.14283/jpad.2022.30",
      "sourceUrl": "https://doi.org/10.14283/jpad.2022.30",
      "verified": true
    },
    {
      "title": "Reduced resting-state brain activity in the “default network” in normal aging",
      "journal": "Cerebral Cortex",
      "year": 2007,
      "citationCount": 1186,
      "doi": "10.1093/cercor/bhm207",
      "sourceUrl": "https://doi.org/10.1093/cercor/bhm207",
      "verified": true
    },
    {
      "title": "Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study",
      "journal": "The Lancet",
      "year": 2001,
      "citationCount": 1054,
      "doi": "10.1016/s0140-6736(00)04725-5",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(00)04725-5",
      "verified": true
    },
    {
      "title": "A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging",
      "journal": "Journal of the Neurological Sciences",
      "year": 1993,
      "citationCount": 922,
      "doi": "10.1016/0022-510x(93)90041-v",
      "sourceUrl": "https://doi.org/10.1016/0022-510x(93)90041-v",
      "verified": true
    },
    {
      "title": "MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines",
      "journal": "The Lancet Neurology",
      "year": 2016,
      "citationCount": 835,
      "doi": "10.1016/s1474-4422(15)00393-2",
      "sourceUrl": "https://doi.org/10.1016/s1474-4422(15)00393-2",
      "verified": true
    },
    {
      "title": "Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy",
      "journal": "New England Journal of Medicine",
      "year": 2006,
      "citationCount": 790,
      "doi": "10.1056/nejmoa054693",
      "sourceUrl": "https://doi.org/10.1056/nejmoa054693",
      "verified": true
    },
    {
      "title": "Cortical lesions in multiple sclerosis",
      "journal": "Brain",
      "year": 1999,
      "citationCount": 765,
      "doi": "10.1093/brain/122.1.17",
      "sourceUrl": "https://doi.org/10.1093/brain/122.1.17",
      "verified": true
    },
    {
      "title": "Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations",
      "journal": "Journal of Neurology Neurosurgery & Psychiatry",
      "year": 2010,
      "citationCount": 755,
      "doi": "10.1136/jnnp.2009.204685",
      "sourceUrl": "https://doi.org/10.1136/jnnp.2009.204685",
      "verified": true
    },
    {
      "title": "Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: An fMRI study",
      "journal": "Human Brain Mapping",
      "year": 2005,
      "citationCount": 732,
      "doi": "10.1002/hbm.20160",
      "sourceUrl": "https://doi.org/10.1002/hbm.20160",
      "verified": true
    },
    {
      "title": "Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2",
      "journal": "Neurology",
      "year": 1996,
      "citationCount": 731,
      "doi": "10.1212/wnl.47.6.1531",
      "sourceUrl": "https://doi.org/10.1212/wnl.47.6.1531",
      "verified": true
    },
    {
      "title": "Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial",
      "journal": "The Lancet",
      "year": 2011,
      "citationCount": 730,
      "doi": "10.1016/s0140-6736(11)61649-8",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(11)61649-8",
      "verified": true
    },
    {
      "title": "Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability",
      "journal": "Annals of Neurology",
      "year": 1999,
      "citationCount": 729,
      "doi": "10.1002/1531-8249(199911)46:5<747::aid-ana10>3.0.co;2-4",
      "sourceUrl": "https://doi.org/10.1002/1531-8249(199911)46:5<747::aid-ana10>3.0.co;2-4",
      "verified": true
    },
    {
      "title": "The clinico-radiological paradox in multiple sclerosis revisited",
      "journal": "Current Opinion in Neurology",
      "year": 2002,
      "citationCount": 701,
      "doi": "10.1097/00019052-200206000-00003",
      "sourceUrl": "https://doi.org/10.1097/00019052-200206000-00003",
      "verified": true
    },
    {
      "title": "Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes",
      "journal": "Neurology",
      "year": 2006,
      "citationCount": 672,
      "doi": "10.1212/01.wnl.0000237641.33768.8d",
      "sourceUrl": "https://doi.org/10.1212/01.wnl.0000237641.33768.8d",
      "verified": true
    },
    {
      "title": "Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis",
      "journal": "Neurology",
      "year": 1998,
      "citationCount": 657,
      "doi": "10.1212/wnl.50.5.1282",
      "sourceUrl": "https://doi.org/10.1212/wnl.50.5.1282",
      "verified": true
    },
    {
      "title": "Prevalence of Amyloid PET Positivity in Dementia Syndromes",
      "journal": "JAMA",
      "year": 2015,
      "citationCount": 642,
      "doi": "10.1001/jama.2015.4669",
      "sourceUrl": "https://doi.org/10.1001/jama.2015.4669",
      "verified": true
    },
    {
      "title": "Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease",
      "journal": "NeuroImage",
      "year": 2004,
      "citationCount": 617,
      "doi": "10.1016/j.neuroimage.2004.07.006",
      "sourceUrl": "https://doi.org/10.1016/j.neuroimage.2004.07.006",
      "verified": true
    },
    {
      "title": "Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers",
      "journal": "The Lancet Neurology",
      "year": 2017,
      "citationCount": 610,
      "doi": "10.1016/s1474-4422(17)30159-x",
      "sourceUrl": "https://doi.org/10.1016/s1474-4422(17)30159-x",
      "verified": true
    },
    {
      "title": "Loss of ‘Small-World’ Networks in Alzheimer's Disease: Graph Analysis of fMRI Resting-State Functional Connectivity",
      "journal": "PLoS ONE",
      "year": 2010,
      "citationCount": 607,
      "doi": "10.1371/journal.pone.0013788",
      "sourceUrl": "https://doi.org/10.1371/journal.pone.0013788",
      "verified": true
    },
    {
      "title": "2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis",
      "journal": "The Lancet Neurology",
      "year": 2021,
      "citationCount": 597,
      "doi": "10.1016/s1474-4422(21)00095-8",
      "sourceUrl": "https://doi.org/10.1016/s1474-4422(21)00095-8",
      "verified": true
    },
    {
      "title": "Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis",
      "journal": "The Lancet Neurology",
      "year": 2005,
      "citationCount": 586,
      "doi": "10.1016/s1474-4422(05)70071-5",
      "sourceUrl": "https://doi.org/10.1016/s1474-4422(05)70071-5",
      "verified": true
    },
    {
      "title": "Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes",
      "journal": "American Journal of Ophthalmology",
      "year": 2006,
      "citationCount": 551,
      "doi": "10.1016/j.ajo.2006.11.003",
      "sourceUrl": "https://doi.org/10.1016/j.ajo.2006.11.003",
      "verified": true
    },
    {
      "title": "A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease",
      "journal": "Alzheimer s Research & Therapy",
      "year": 2017,
      "citationCount": 551,
      "doi": "10.1186/s13195-017-0318-y",
      "sourceUrl": "https://doi.org/10.1186/s13195-017-0318-y",
      "verified": true
    },
    {
      "title": "Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease",
      "journal": "JAMA Neurology",
      "year": 2021,
      "citationCount": 541,
      "doi": "10.1001/jamaneurol.2021.4161",
      "sourceUrl": "https://doi.org/10.1001/jamaneurol.2021.4161",
      "verified": true
    },
    {
      "title": "The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features",
      "journal": "Brain",
      "year": 2015,
      "citationCount": 532,
      "doi": "10.1093/brain/awv191",
      "sourceUrl": "https://doi.org/10.1093/brain/awv191",
      "verified": true
    },
    {
      "title": "Multiple sclerosis progression: time for a new mechanism-driven framework",
      "journal": "The Lancet Neurology",
      "year": 2022,
      "citationCount": 528,
      "doi": "10.1016/s1474-4422(22)00289-7",
      "sourceUrl": "https://doi.org/10.1016/s1474-4422(22)00289-7",
      "verified": true
    },
    {
      "title": "Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines",
      "journal": "Brain",
      "year": 2019,
      "citationCount": 523,
      "doi": "10.1093/brain/awz144",
      "sourceUrl": "https://doi.org/10.1093/brain/awz144",
      "verified": true
    },
    {
      "title": "Inter-and Intraobserver Reproducibility of Cerebral Atrophy Assessment on MRI Scans with Hemispheric Infarcts",
      "journal": "European Neurology",
      "year": 1996,
      "citationCount": 522,
      "doi": "10.1159/000117270",
      "sourceUrl": "https://doi.org/10.1159/000117270",
      "verified": true
    },
    {
      "title": "Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias",
      "journal": "The Lancet Neurology",
      "year": 2020,
      "citationCount": 507,
      "doi": "10.1016/s1474-4422(20)30314-8",
      "sourceUrl": "https://doi.org/10.1016/s1474-4422(20)30314-8",
      "verified": true
    },
    {
      "title": "Grey matter pathology in multiple sclerosis",
      "journal": "The Lancet Neurology",
      "year": 2008,
      "citationCount": 506,
      "doi": "10.1016/s1474-4422(08)70191-1",
      "sourceUrl": "https://doi.org/10.1016/s1474-4422(08)70191-1",
      "verified": true
    },
    {
      "title": "Intracortical Lesions in Multiple Sclerosis: Improved Detection with 3D Double Inversion-Recovery MR Imaging",
      "journal": "Radiology",
      "year": 2005,
      "citationCount": 504,
      "doi": "10.1148/radiol.2361040450",
      "sourceUrl": "https://doi.org/10.1148/radiol.2361040450",
      "verified": true
    },
    {
      "title": "Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression",
      "journal": "JAMA Neurology",
      "year": 2014,
      "citationCount": 502,
      "doi": "10.1001/jamaneurol.2013.5993",
      "sourceUrl": "https://doi.org/10.1001/jamaneurol.2013.5993",
      "verified": true
    },
    {
      "title": "Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study",
      "journal": "The Lancet",
      "year": 2007,
      "citationCount": 499,
      "doi": "10.1016/s0140-6736(07)61194-5",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(07)61194-5",
      "verified": true
    },
    {
      "title": "Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis",
      "journal": "The Lancet",
      "year": 1999,
      "citationCount": 498,
      "doi": "10.1016/s0140-6736(98)03053-0",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(98)03053-0",
      "verified": true
    },
    {
      "title": "Arterial Spin Labeling Perfusion of the Brain: Emerging Clinical Applications",
      "journal": "Radiology",
      "year": 2016,
      "citationCount": 490,
      "doi": "10.1148/radiol.2016150789",
      "sourceUrl": "https://doi.org/10.1148/radiol.2016150789",
      "verified": true
    },
    {
      "title": "Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial",
      "journal": "The Lancet Neurology",
      "year": 2008,
      "citationCount": 480,
      "doi": "10.1016/s1474-4422(08)70200-x",
      "sourceUrl": "https://doi.org/10.1016/s1474-4422(08)70200-x",
      "verified": true
    },
    {
      "title": "Association between pathological and MRI findings in multiple sclerosis",
      "journal": "The Lancet Neurology",
      "year": 2012,
      "citationCount": 479,
      "doi": "10.1016/s1474-4422(12)70003-0",
      "sourceUrl": "https://doi.org/10.1016/s1474-4422(12)70003-0",
      "verified": true
    },
    {
      "title": "PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS",
      "journal": "DIAL (Catholic University of Leuven)",
      "year": 2001,
      "citationCount": 472,
      "doi": null,
      "sourceUrl": "https://openalex.org/W2513768836",
      "verified": true
    },
    {
      "title": "Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis",
      "journal": "Human Molecular Genetics",
      "year": 2008,
      "citationCount": 468,
      "doi": "10.1093/hmg/ddn388",
      "sourceUrl": "https://doi.org/10.1093/hmg/ddn388",
      "verified": true
    },
    {
      "title": "Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: Interobserver reliability",
      "journal": "Journal of Neurology",
      "year": 1995,
      "citationCount": 463,
      "doi": "10.1007/bf00868807",
      "sourceUrl": "https://doi.org/10.1007/bf00868807",
      "verified": true
    },
    {
      "title": "Accumulation of hypointense lesions (\"black holes\") on T <sub>1</sub> spin-echo MRI correlates with disease progression in multiple sclerosis",
      "journal": "Neurology",
      "year": 1996,
      "citationCount": 462,
      "doi": "10.1212/wnl.47.6.1469",
      "sourceUrl": "https://doi.org/10.1212/wnl.47.6.1469",
      "verified": true
    },
    {
      "title": "Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis",
      "journal": "Annals of Neurology",
      "year": 1996,
      "citationCount": 444,
      "doi": "10.1002/ana.410390104",
      "sourceUrl": "https://doi.org/10.1002/ana.410390104",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:15.000Z",
  "openalexId": "https://openalex.org/A5064378373"
}